A novel regulatory facet for hypertriglyceridemia: the role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis (2023)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.plipres.2022.101197
- Subjects: ESTUDOS SOROEPIDEMIOLÓGICOS; LIPOPROTEÍNAS; MICRORNAS; FATORES DE RISCO; DOENÇAS CARDIOVASCULARES
- Language: Inglês
- Imprenta:
- Source:
- Título: Progress in lipid research
- ISSN: 0163-7827
- Volume/Número/Paginação/Ano: v. 89, article ID 101197, 14p, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
KHALIFEH, Masoumeh et al. A novel regulatory facet for hypertriglyceridemia: the role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis. Progress in lipid research, v. 89, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/51437. Acesso em: 09 fev. 2026. -
APA
Khalifeh, M., Santos Filho, R. D. dos, Oskuee, R. K., Badiee, A., Aghaee-Bakhtiari, S. H., & Sahebkar, A. (2023). A novel regulatory facet for hypertriglyceridemia: the role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis. Progress in lipid research, 89. doi:10.1016/j.plipres.2022.101197 -
NLM
Khalifeh M, Santos Filho RD dos, Oskuee RK, Badiee A, Aghaee-Bakhtiari SH, Sahebkar A. A novel regulatory facet for hypertriglyceridemia: the role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis [Internet]. Progress in lipid research. 2023 ; 89[citado 2026 fev. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51437 -
Vancouver
Khalifeh M, Santos Filho RD dos, Oskuee RK, Badiee A, Aghaee-Bakhtiari SH, Sahebkar A. A novel regulatory facet for hypertriglyceridemia: the role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis [Internet]. Progress in lipid research. 2023 ; 89[citado 2026 fev. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/51437 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre o DOI: 10.1016/j.plipres.2022.101197 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
